ER
Edward M Rudnic
President and CEODirector

Edward M Rudnic insider trades: MiddleBrook Pharmaceuticals (MBRK) stock sales

President and CEO, MiddleBrook Pharmaceuticals Last trade Nov 26, 2007 14 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2006
2
Companies
last trade 2007

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Edward reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 26, 2007MBRK↓ Sell$13K
Nov 23, 2007MBRK↓ Sell$13K
Nov 19, 2007MBRK↓ Sell$20K
Oct 18, 2007MBRK↓ Sell$18K
Oct 17, 2007MBRK↓ Sell$42K
Sep 18, 2007MBRK↓ Sell$90K
Aug 24, 2007MBRK↓ Sell$30K
Aug 23, 2007MBRK↓ Sell$63K
Nov 21, 2006AVNC↓ Sell$40K
Sep 20, 2006AVNC↓ Sell$224K
Feb 16, 2006AVNC↓ Sell$199K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Edward M Rudnic's insider trades

Edward M Rudnic is President and CEO at MiddleBrook Pharmaceuticals (MBRK). Since Feb 16, 2006, Edward has reported no open-market purchases and 11 sales worth $751K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MBRK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.